Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dalbavancin manufacturers

7 products found

Filters

7 products found

dalbavancin

Solution for injection 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Comments
Dossier availability date: Q1 2024
Manufacturer #2346

Manufacturer usually replies in 9 days

dalbavancin

Vials 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
EU MA's Running
Manufacturer #21467

Manufacturer usually replies in 9 days

dalbavancin

Solution for infusion 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Dossier availability date: Q3 2024
Manufacturer #21467

Manufacturer usually replies in 9 days

dalbavancin

Powder for solution for infusion 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

dalbavancin

Injection 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Antibiotic; Status: Q2 2024 Under Development
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 10 days

dalbavancin

Vials, lyophilized injection 500 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 8 days

dalbavancin

Injection 500 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, TGA, WHO
Manufacturer #12792

Manufacturer usually replies in 6 days